secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akari Therapeutics Plc (AKTX)
CIK:        0001541157
Form:       8-K
Filed at:   2026-06-26T21:15:40+00:00
Accession:  0001493152-26-030341
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Akari Therapeutics consolidates remaining private placement closings, issues 980,395 ADSs
--------------------------------------------------------------------------------

- Combined second and third closings into single closing on June 26, 2026; issued 980,395 ADSs (or prefunded warrants).
- First closing of 490,193 ADSs occurred May 27, 2026, under the original three-tranche structure.
- Delivery of Series H, I, and J warrants contingent on shareholder approval at June 30, 2026 annual meeting.
- No other changes to the securities purchase agreement besides consolidation of closings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1541157/000149315226030341/0001493152-26-030341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1541157/000149315226030341/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-030341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer